Marcos González Díaz-rekin lankidetzan egindako argitalpenak (11)

2012

  1. Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4 and MLL-germline acute lymphoblastic leukemia

    Leukemia, Vol. 26, Núm. 11, pp. 2360-2366

2005

  1. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A multicenter study by the PETHEMA Group

    Journal of Clinical Oncology, Vol. 23, Núm. 30, pp. 7632-7640

2004

  1. Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: Effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease

    Transfusion, Vol. 44, Núm. 5, pp. 771-776

1997

  1. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors

    Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458

1991

  1. Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes

    Medicina clínica, Vol. 97, Núm. 10, pp. 369-372

  2. The value of the immunological subtypes and individual markers compared to classical parameters in the prognosis of acute lymphoblastic leukemia

    Hematological Oncology, Vol. 9, Núm. 1, pp. 33-42

1990

  1. Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia.

    Haematologia, Vol. 23, Núm. 1, pp. 49-56

1985

  1. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease

    Neoplasma, Vol. 32, Núm. 2, pp. 191-198

1984

  1. Biphenotypic leukemia in treated Hodgkin's disease.

    Journal of clinical pathology

  2. Fenotipos inmunológicos de las leucemias linfoblásticas agudas y sus correlaciones clínico-biológicas.

    Sangre, Vol. 29, Núm. 5, pp. 849-860

1983

  1. Infecciones en mieloma múltiple.

    Revista Clinica Espanola, Vol. 168, Núm. 4, pp. 247-248